TipRanks
Aldeyra Therapeutics (DE:137)
FRANKFURT:137
Germany Market
137
Aldeyra Therapeutics
RESEARCH TOOLSreports

Aldeyra Therapeutics (137) Stock News & Sentiment

0 Followers
Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed
Premium
Ratings
Aldeyra Therapeutics: Neutral Rating Maintained Amid FDA Uncertainty; $2 Price Target Reaffirmed
1d ago
ALDX
Aldeyra Pursues FDA Dispute Over Dry Eye Drug
Premium
Company Announcements
Aldeyra Pursues FDA Dispute Over Dry Eye Drug
2d ago
8K
ALDX
Analyst Maintains Hold on Aldeyra Amid FDA Uncertainty Over Reproxalap’s Regulatory Path
Premium
Ratings
Analyst Maintains Hold on Aldeyra Amid FDA Uncertainty Over Reproxalap’s Regulatory Path
2M ago
ALDX
Aldeyra Therapeutics Leases New Concord Headquarters Space
Premium
Company Announcements
Aldeyra Therapeutics Leases New Concord Headquarters Space
2M ago
8K
ALDX
ALDX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ALDX Upcoming Earnings Report: What to Expect?
2M ago
ALDX
Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support
Premium
Company Announcements
Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support
4M ago
8K
ALDX
Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims
Premium
Market News
Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims
4M ago
ALDX
More DE:137 News >

137 News on the Web

Aldeyra sees operational cash runway into 2029
TipRanks News
Neutral
Aldeyra to submit Formal Dispute Resolution Request to FDA for reproxalap
TipRanks News
Neutral
Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why
Zacks
Neutral
AQR Capital Management Expands Aldeyra Therapeutics (ALDX) Stake Despite Steep Stock Decline
GuruFocus News
Bullish
Levicept Ltd (ALDX) Appoints Darlene Deptula-Hicks as CFO Amid Positive Phase II Results
GuruFocus News
Bullish
Aldeyra Therapeutics Adds Independent Director, Affirms Governance Support
TipRanks News
Neutral
Top Executive Makes Bold Insider Move at Aldeyra Therapeutics
TipRanks News
Neutral
Todd Brady Increases Stake in Aldeyra Therapeutics Inc with Significant Share Purchase
GuruFocus News
Bullish

News Score - Last 7 Days

Neutral
DE:137
Sector Average
Media Buzz
This Week8 articles
Weekly Average8.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:137’s Media Buzz Sentiment?
8 articles about DE:137 were published this week. In an average week, 8.5 articles are published.
    What is DE:137’s weekly average amount of articles?
    In an average week, 8.5 articles about DE:137 are published.
      What is DE:137’s News Sentiment?
      50% of articles about DE:137 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week